Last reviewed · How we verify

A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy

NCT05179460 COMPLETED

The purpose of this study is to evaluate incidence and prevalence rates of the study endpoints (pigmentary maculopathy \[PM\]/ pigmentary retinopathy \[PR\]/Any, PM/PR/ pentosan polysulfate sodium \[PPS\], and PM/PR/Non-PPS) in relation to PPS exposure, and in participants with interstitial cystitis (IC) but not exposed to PPS; changes in visual acuity (VA) over time; participant treatment journey leading to PPS treatment, and potential risk factors associated with the occurrence of PM/PR/PPS.

Details

Lead sponsorJanssen Research & Development, LLC
StatusCOMPLETED
Enrolment2
Start dateTue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri May 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Countries

United States